NCT03517683

Brief Summary

Hypotension is the most common complication of neuraxial anesthesia in obstetric patients and its prevalence in cesarean section is about 50-90%. Maternal hypotension causes unpleasant symptoms such as nausea, vomiting, loss of consciousness, respiratory depression, and cardiac arrest. Hypotension may reduce placental perfusion and result in fetal acidosis and neurological injury. Several techniques have been proposed to prevent hypotension. The recommended spinal block height to ensure patient comfort for Cesarean delivery is T4-6. Clinically, it is desirable that the spread of local anesthetic through the cerebrospinal fluid (CSF) achieves a sensory level no higher than the T4 dermatome to avoid extensive sympathetic block. It is also important that the spinal block level be no lower than T6 to avoid patient discomfort during peritoneal manipulation and uterine exteriorization. The effect of injection speed on spread of spinal anesthesia is controversial. Several studies have demonstrated more extensive spread with faster injection while others report either greater spread with slower injection, or no difference. Slow injection of hyperbaric bupivacaine 10 mg over 60 and 120 sec has been shown to reduce the incidence and severity of hypotension during Cesarean delivery under spinal anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
159

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2018

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 19, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 7, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
Last Updated

March 7, 2019

Status Verified

March 1, 2019

Enrollment Period

10 months

First QC Date

April 19, 2018

Last Update Submit

March 6, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of hypotension

    demonstrate the effect of the injection speed (high and low) of the anesthesia mixture intrathecally on the incidence of hypotension measured through mean arterial pressure

    within one hour

Secondary Outcomes (2)

  • block level

    5 and 10 minutes after performing the injection

  • Number of participants experiencing nausea and vomiting

    within one hour

Study Arms (2)

Low speed

EXPERIMENTAL

Patients will receive intrathecal injection of the anesthetic mixture in a slow speed (1ml in 15 seconds)

Other: Low speed

High speed

ACTIVE COMPARATOR

Patients will receive intrathecal injection of the anesthetic mixture in a high speed (1ml in 5 seconds)

Other: High speed

Interventions

Speed of intrathecal injection will be 1ml in 15 seconds

Low speed

speed of intrathecal injection will be 1ml in 5 seconds

High speed

Eligibility Criteria

Age17 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients with American Society of Anesthesiology physical status 1 and 2
  • and scheduled for elective c-section surgery under spinal anesthesia

You may not qualify if:

  • Patients with cardiac and psychological problems
  • Patients who take sedatives or narcotics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Makassed General Hospital

Beirut, Lebanon

Location

MeSH Terms

Conditions

Hypotension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairperson of Anesthesia and Pain Management Department

Study Record Dates

First Submitted

April 19, 2018

First Posted

May 7, 2018

Study Start

April 15, 2018

Primary Completion

January 31, 2019

Study Completion

January 31, 2019

Last Updated

March 7, 2019

Record last verified: 2019-03

Locations